PMID: 11491164

Massie RJ, Poplawski N, Wilcken B, Goldblatt J, Byrnes C, Robertson C
Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C.
Eur Respir J. 2001 Jun;17(6):1195-200., [PubMed]
Sentences
No. Mutations Sentence Comment
3 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:3:122
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:3:147
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 11491164:3:131
status: NEW
view ABCC7 p.Arg117Cys details
ABSTRACT: Compound heterozygotes for a severe cystic fibrosis transmembrane conductance regulator (CFTR) mutation and the R117H or R117C mutation (R117H/ C) have clinical presentations that vary from classic cystic fibrosis (CF) to an incidental genetic finding. Login to comment
4 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:4:167
status: NEW
view ABCC7 p.Arg117His details
The aim of this study was to assess the influence of the intron-8 polythymidine sequence (IVS8) on the relationship between genotype and phenotype of individuals with R117H/C. Login to comment
5 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:5:21
status: NEW
view ABCC7 p.Arg117His details
All individuals with R117H/C known to CF clinics in Australia and New Zealand were retrospectively studied by collecting information on genotype, age, pancreatic status, sweat electrolytes, sputum microbiology and pulmonary function. Login to comment
6 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:6:31
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 11491164:6:50
status: NEW
view ABCC7 p.Arg117Cys details
Forty-one individuals (39 with R117H and two with R117C), 16 on an IVS8-5T background and 25 on an IVS8-7T background were identified. Login to comment
7 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:7:69
status: NEW
view ABCC7 p.Arg117His details
Twelve individuals presented clinically, four were siblings of known R117H/C compound heterozygotes and 25 were detected by newborn screening. Login to comment
8 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:8:130
status: NEW
view ABCC7 p.Arg117His details
Eleven of 14 of the IVS8-5T group (78%) with sweat chloride results available had sweat Clw60 mmol?L-1 compared to 5 (20%) of the R117H/7T group (Chi-squared~10.4, p~0.001). Login to comment
11 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:11:37
status: NEW
view ABCC7 p.Arg117His details
In conclusion, most individuals with R117H/C on a IVS8-5T background have an elevated sweat chloride and clinical cystic fibrosis, which in some cases is severe. Login to comment
12 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:12:22
status: NEW
view ABCC7 p.Arg117His details
Most individuals with R117H/C on an IVS8-7T background do not have clinical cystic fibrosis but should be followed for the development of clinical disease. Login to comment
15 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:15:173
status: NEW
view ABCC7 p.Arg117His details
Correspondence: R.J.H. Massie Dept of Respiratory Medicine Royal Children9s Hospital Melbourne 3052 Australia Fax: 61 393491289 Keywords: Cystic fibrosis genotype phenotype R117H Received: June 26 2000 Accepted after revision January 15 2001 The correlation between genotype and phenotype in cystic fibrosis (CF) is not always clear [1]. Login to comment
16 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:16:140
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:16:156
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 11491164:16:149
status: NEW
view ABCC7 p.Arg117Cys details
In general, individuals who are compound heterozygotes for a severe cystic fibrosis transmembrane conductance regulator (CFTR) mutation and R117H or R117C (R117H/C) have milder disease. Login to comment
18 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:18:0
status: NEW
view ABCC7 p.Arg117His details
R117H/C are class IV mutations associated with the production of a CFTR protein which has altered channel properties [3, 4]. Login to comment
19 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:19:27
status: NEW
view ABCC7 p.Arg117His details
Chloride transport through R117H/C CFTR is reduced and this is thought to explain the milder phenotype [3, 4]. Login to comment
20 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:20:34
status: NEW
view ABCC7 p.Arg117His details
The variable presentation amongst R117H/C compound heterozygotes may be explained, in part, by the efficiency of exon-9 splicing. Login to comment
25 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:25:46
status: NEW
view ABCC7 p.Arg117His details
The variable presentation of individuals with R117H/C makes it difficult to be certain of the clinical outcome. Login to comment
26 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:26:265
status: NEW
view ABCC7 p.Arg117His details
However, the widespread availability of CFTR gene mutation testing, in particular through newborn screening programmes and antenatal testing, has created the need to predict the prognosis of individuals who are compound heterozygotes for a severe CFTR mutation and R117H/C who may be asymptomatic at the time of testing. Login to comment
28 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:28:84
status: NEW
view ABCC7 p.Arg117His details
The criteria includes the presence of two disease producing CFTR mutations of which R117H/C are only considered disease producing mutations when in cis with IVS8-5T [8]. Login to comment
29 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:29:80
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:29:352
status: NEW
view ABCC7 p.Arg117His details
Despite this, there are reports of individuals with CF-like conditions who have R117H/C with the IVS8-7T allele [5, 9, 10] and there Eur Respir J 2001; 17: 1195-1200 Printed in UK - all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 is no definitive information as to strength of the relationship between R117H/C, the IVS8 polythymidine sequence and the clinical outcome. Login to comment
30 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:30:117
status: NEW
view ABCC7 p.Arg117His details
The aim of this study was to assess the relationship between genotype and phenotype of individuals known to have the R117H/C mutation and the influence of the IVS8 polythymidine sequence. Login to comment
32 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:32:137
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 11491164:32:146
status: NEW
view ABCC7 p.Arg117Cys details
Information was requested regarding all individuals, alive or deceased, who had been seen in their clinic and who were known to have the R117H or R117C mutation. Login to comment
33 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:33:0
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:33:125
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:33:157
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 11491164:33:10
status: NEW
view ABCC7 p.Arg117Cys details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 11491164:33:135
status: NEW
view ABCC7 p.Arg117Cys details
R117H and R117C have been considered to be functionally equivalent [11] and have been combined in the analysis, referring to R117H and R117C collectively as R117H/C. Login to comment
35 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:35:192
status: NEW
view ABCC7 p.Arg117His details
Individuals were known to CF clinic directors and Clinical Genetics Services on the basis of either a clinical presentation (symptoms of CF or a sibling of a patient compound heterozygote for R117H/C) or identification through newborn screening. Login to comment
39 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11491164:39:63
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:39:94
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 11491164:39:84
status: NEW
view ABCC7 p.Arg553* details
One Australian centre (South Australia) includes the mutations G551D, G452X, DI507, R553X and R117H as part of routine screening of infants with an elevated IRT [12]. Login to comment
41 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11491164:41:212
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:41:205
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 11491164:41:219
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 11491164:41:241
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 11491164:41:271
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 11491164:41:264
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 11491164:41:233
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 11491164:41:226
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 11491164:41:278
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 11491164:41:286
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 11491164:41:257
status: NEW
view ABCC7 p.Arg560Thr details
Infants with a positive (w60 mmol?L-1 ) or borderline (40 - 60 mmol?L-1 ) sweat chloride and in whom there is an unidentified mutation are referred for an extended mutation analysis which includes: DF508, R117H, G551D, A455E, G542X, N1303K, W1282X, 1717-1, R560T, R347P, R334W, R1162X, S549N, 621z1, 3849z10CwT, and the IVS8 polythymidine sequence. Login to comment
45 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:45:0
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 11491164:45:126
status: NEW
view ABCC7 p.Arg117Cys details
R117H was detected by ARMS (Western Australia, New South Wales, Victoria, Tasmania, New Zealand) or ASO (South Australia) and R117C was detected using a restriction enzyme digest (Western Australia, New South Wales, Victoria, Tasmania), ASO (South Australia) or ARMS (New Zealand). Login to comment
54 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:54:44
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:54:56
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 11491164:54:70
status: NEW
view ABCC7 p.Arg117Cys details
Results Genotype Forty-one individuals with R117H/C (39 R117H and two R117C) being followed at one of the CF clinics in Australia and New Zealand were identified. Login to comment
56 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:56:66
status: NEW
view ABCC7 p.Arg117His details
Thirty-four of the 39 individuals were compound heterozygotes for R117H/C and DF508. Login to comment
57 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 11491164:57:69
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:57:59
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:57:75
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:57:154
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 11491164:57:53
status: NEW
view ABCC7 p.Gly542* details
Two of the individuals had a second severe mutation (G542X/R117H and G551D/R117H), four had an unknown second mutation and one patient was homozygous for R117H. Login to comment
58 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:58:24
status: NEW
view ABCC7 p.Arg117His details
Sixteen individuals had R117H on an IVS8-5T background and 25 on an IVS8-7T background. Login to comment
59 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:59:102
status: NEW
view ABCC7 p.Arg117His details
The phase of each chromosome was unknown, preventing identification of the direct association between R117H and the IVS8 polythymidine sequence. Login to comment
60 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:60:107
status: NEW
view ABCC7 p.Arg117His details
However, previous studies have indicated that where present, IVS8-9T occurs in cis with DF508 [5] and that R117H is the only mutation that occurs in cis with IVS8-5T [18]. Login to comment
62 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:62:172
status: NEW
view ABCC7 p.Arg117His details
Presentation Twenty-five of the 41 (61%) individuals were discovered through newborn screening, 12 (29%) because of respiratory symptoms and four (10%) were siblings of an R117H/C compound heterozygote (three had a younger sibling with a positive newborn screening test and one had a sibling presenting clinically). Login to comment
67 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:67:24
status: NEW
view ABCC7 p.Arg117His details
Both PI individuals had R117H/C on an IVS8-5T background. Login to comment
83 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:83:95
status: NEW
view ABCC7 p.Arg117His details
Discussion This study provides evidence that the variable presentation of individuals with the R117H/C mutation is associated with differences in the IVS8. Login to comment
84 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:84:22
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:84:145
status: NEW
view ABCC7 p.Arg117His details
Most individuals with R117H/C and the IVS8-5T allele fulfil clinical and sweat test criteria for the diagnosis of CF while most individuals with R117H/C and the IVS8-7T allele do not [8]. Login to comment
87 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:87:81
status: NEW
view ABCC7 p.Arg117His details
In general, individuals who are compound heterozygotes for a severe mutation and R117H/C on an IVS8-5T background have pancreatic sufficient CF which is mild compared to individuals with two severe mutations [2]. Login to comment
94 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:94:333
status: NEW
view ABCC7 p.Arg117His details
Symptoms of established suppurative lung disease were present in some of the older IVS8-7T individuals, raising the possibility that significant lung disease may develop in more of the IVS8-7T group with time. This study is similar to that of KIESEWETTER et al. [5] who studied 38 pancreatic sufficient CF individuals with the DF508/R117H genotype, of whom 31 had the IVS8-5T allele and seven the IVS8-7T allele. Login to comment
95 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:95:21
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:95:137
status: NEW
view ABCC7 p.Arg117His details
A further nine DF508/R117H individuals were studied, eight males had CAVD only and one female who was asymptomatic, and in each case the R117H was associated with the IVS8-7T allele. Login to comment
96 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:96:103
status: NEW
view ABCC7 p.Arg117His details
The difference between IVS8-5T and IVS8-7T distribution amongst symptomatic individuals with the DF508/R117H genotype was significant (Chi-squared~15.2, pv0.001). Login to comment
97 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:97:119
status: NEW
view ABCC7 p.Arg117His details
This study recognized the need for IVS8 polythymidine analysis to explain the variability amongst individuals with the R117H mutation. Login to comment
98 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:98:42
status: NEW
view ABCC7 p.Arg117His details
Other studies have found individuals with R117H on a IVS8-7T background to have pulmonary disease. Login to comment
99 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:99:49
status: NEW
view ABCC7 p.Arg117His details
DEAN et al. [9] reported a 56-yr-old female with R117H/IVS8-7T who had chronic bronchitis from the age of 10 yrs, complicated by allergic bronchopulmonary aspergillosis (ABPA). Login to comment
101 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:101:79
status: NEW
view ABCC7 p.Arg117His details
Similarly, one patient in a series of sweat test negative ABPA individuals had R117H a IVS8-7T background and could be considered to have a mild form of CF [10]. Login to comment
102 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:102:65
status: NEW
view ABCC7 p.Arg117His details
The variability of clinical presentation of individuals with the R117H/C mutations is largely, but not entirely explained by the IVS8 polythymidine sequence. Login to comment
106 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:106:105
status: NEW
view ABCC7 p.Arg117His details
The importance of understanding the role of the IVS8 polythymidine sequence amongst individuals with the R117H mutation was highlighted in a recent report by CHMIEL et al. [20]. Login to comment
107 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:107:90
status: NEW
view ABCC7 p.Arg117His details
In this report an infant was diagnosed with CF on the basis of the detection of DF508 and R117H in cord blood but without IVS8 polythymidine sequencing being performed until much later. Login to comment
109 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:109:4
status: NEW
view ABCC7 p.Arg117His details
The R117H was found to be on an IVS8-7T background and the diagnosis of CF was changed, but not without considerable emotional cost to the family. Login to comment
112 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:112:3
status: NEW
view ABCC7 p.Arg117His details
If R117H/C is detected then it is imperative that intron-8 polythymidine sequence analysis be performed to offer some guidance as to the likely phenotype. Login to comment
113 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:113:60
status: NEW
view ABCC7 p.Arg117His details
Most individuals with a severe cystic fibrosis mutation and R117H/C on the intron-8 polythymidine sequence-5T background will have an elevated sweat chlorine and clinical features of cystic fibrosis, which in some cases are severe and associated with an early death. Login to comment
114 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:114:22
status: NEW
view ABCC7 p.Arg117His details
Most individuals with R117H/C on the intron-8 polythymidine sequence-7T background do not have clinical features of cystic fibrosis although over half have elevated or borderline sweat chloride. Login to comment
115 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 11491164:115:17
status: NEW
view ABCC7 p.Arg117His details
Individuals with R117H/C on the intron-8 polythymidine sequence-7T background should be followed for the potential to develop clinical disease. Login to comment